Pulse Biosciences, Inc. PLSE Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $31K— | —— | -$193K— | —— | $0— | ||
| $6.59M-10.1% | $7.33M-16.5% | $8.78M+7.3% | $8.19M+5.9% | $7.73M-19.5% | ||
| -$18.58M-6.6% | -$17.43M+10.1% | -$19.39M-1.1% | -$19.17M-14.1% | -$16.8M+13.4% | ||
| -$18.9M-5.0% | -$17.99M+10.5% | -$20.1M-0.5% | -$20.01M-12.7% | -$17.76M+11.1% | ||
| -$19.15M-4.9% | -$18.25M+10.4% | -$20.37M-0.5% | -$20.28M-12.4% | -$18.04M+10.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s profit margins?
- Gross margin is -4067.5% and operating margin is -10392.1%, with a -9929.0% net margin.
- Where does Pulse Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.